|
Congratulations to Dr. Aupperle (Principal Investigator) and Dr. Misaki (Co-Investigator) on the funding of the innovative project, Neuromodulatory Enhancement of Hope in the Treatment of Suicide (NEU-Hope). The study will evaluate whether a targeted neurofeedback intervention focused on the ventromedial prefrontal cortex (vmPFC) can help reduce the risk of suicide attempt recurrence in individuals with major depressive disorder. The project involves collaboration with MPI Dr. Christine Cha at Yale School of Medicine. The long-term goal is to develop more effective neuromodulation-based treatments that could serve as either an alternative or an addition to existing acute interventions for patients at high suicide risk. We look forward to the important contributions this work will make to advancing suicide prevention research and treatment! 
0 Comments
Dr. Boris Birmaher - July 28, 2026
"Diagnostic Challenges in Pediatric Bipolar Disorder: Clinical Assessment, Research Insights, and Differential Diagnosis" William K. Warren, Jr. Frontiers in Neuroscience Lecture 12:00 pm - 1:00 pm Program in the LPCH auditorium Dr. Birmaher is the Endowed Chair in Early Onset Bipolar Disease and Distinguished Professor of Psychiatry at the University of Pittsburgh, School of Medicine, and the Co-Director of the Child and Adolescent Bipolar Spectrum Services. He received his medical degree from Valle University in Cali, Columbia; completed training in general psychiatry at the Hebrew University in Jerusalem, Israel, and child psychiatry at Columbia University, New York. Dr. Birmaher is a leading expert in the study and treatment of pediatric mood and anxiety disorders. His research has focused extensively on predictors, risk factors, longitudinal course, and treatment of childhood-onset bipolar disorder. Through his extensive research, clinical leadership, and mentorship, Dr. Birmaher has significantly advanced our understanding of risk factors for mood and anxiety disorders, contributed to the development of innovative treatments, and trained the next generation of clinicians, educators, and researchers dedicated to improving the lives of children, adolescents, and young adults with psychiatric disorders. Learning objectives:
For Physicians: Saint Francis Health System is accredited by the Oklahoma State Medical Association to provide continuing medical education for physicians. Saint Francis Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For Psychologists: The Oklahoma State Board of Examiners of Psychologists recognizes AMA PRA Category 1 credit(s)™. Saint Francis Health System is accredited by the OSMA. For Social Workers: Saint Francis Health System is an approved CE Provider for the Oklahoma State Board of Licensed Social Workers. This event if approved for 1 hours, Category 1 Clinical. (CEP Number - 20260007) For CADCs and LADCs Saint Francis Health System is accredited as a provider of continuing education programs for CADCs and LADCs through the Oklahoma Board of Licensed Alcohol and Drug Counselors. (1 hour) (Provider Number - TBD) The LPC/LMFT Saint Francis Health System is a Board approved CE Provider for the State Board of Behavioral Health Licensure (BBHL). This course is approved for 1 hour of CE. For questions, email: Ally Deatherage at [email protected] Dr. Paulus was presented with the 2026 Award for Research in Psychiatry from the American Psychiatric Association Foundation yesterday in San Francisco. This honor recognizes Dr. Paulus's distinguished contributions that have had major impacts in the field of psychiatric research. We are proud to celebrate this well-deserved recognition.  |
Archives
July 2026
Categories
All
|
RSS Feed
VISIT LIBR6655 South Yale Ave. Tulsa, OK 74136
918.502.5100 | [email protected] |
|
© 2009-2026. All Rights Reserved. Laureate Institute for Brain Research
Site powered by Laureate Institute for Brain Research